Contact
Please use this form to send email to PR contact of this press release:
Neuralstem Announces Initiation of Phase 2 Clinical Trial of NSI-189 in Ischemic Stroke
TO:
Please use this form to send email to PR contact of this press release:
Neuralstem Announces Initiation of Phase 2 Clinical Trial of NSI-189 in Ischemic Stroke
TO: